Gene · 7004
Papers1,824
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
61 to 80 of 1,824
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Expanding the toolbox to develop IAP-based degraders of TEAD transcription factors. | Commun Chem | 2026 | 41554911 | PubTator, text mining | PubMed |
| TEAD4-driven GPX8 promotes temozolomide resistance in glioma by facilitating CTHRC1 expression to suppress mitochondrial oxidative stress. | Naunyn Schmiedebergs Arch Pharmacol | 2026 | 41553494 | PubTator, text mining | PubMed |
| Association between elevated PRIM1 expression and poor prognosis in human urothelial carcinoma. | J Taibah Univ Med Sci | 2026 | 41550244 | PubTator, text mining | PubMed |
| Development of a TEAD-independent reporter system for specific and sensitive measurement of YAP/TAZ activity. | Biochim Biophys Acta Mol Cell Res | 2026 | 41534572 | PubTator, text mining | PubMed |
TEAD4 and RXRA Regulate the Function of Nucleus Pulposus Cells in Intervertebral Disc Degeneration Via the TNF-α/NF-κB Pathway: An Integrated Analysis of Single-Cell RNA-Seq, Bulk RNA-Seq, and In Vitro Validation. | Appl Biochem Biotechnol | 2026 | 41511606 | PubTator, text mining | PubMed |
| Small Nucleolar RNA Snord17 Promotes Self-Renewal of Intestinal Stem Cells through Yy2 mRNA Export and Tead4 Activation. | Adv Sci (Weinh) | 2026 | 41486589 | PubTator, text mining | PubMed |
| Mechanosensor YAP orchestrates human neural rosette morphogenesis via TEAD4-LEF1 transcriptional nexus. | Sci China Life Sci | 2026 | 41324880 | PubTator, text mining | PubMed |
| Integrated analysis identifies conserved transcription factors TCF12, E2F1, and TEAD4 with diagnostic and therapeutic value in osteoarthritis subchondral bone. | Genes Genomics | 2026 | 41296172 | PubTator, text mining | PubMed |
| Laminin β1 stimulates the Hippo-YAP1 pathway to advance the progression and lenvatinib resistance in hepatocellular carcinoma. | Int J Biol Macromol | 2026 | 41274476 | PubTator, text mining | PubMed |
| ACTL6A accelerates the progression of NSCLC through hippo/YAP signaling axis and TAMs-mediated immune regulation. | Int Immunopharmacol | 2026 | 41223612 | PubTator, text mining | PubMed |
| Unraveling Resistance Mechanisms to Gαq Pathway Inhibition in Uveal Melanoma: Insights from Signaling-Activation Library Screening. | Cancers (Basel) | 2025 | 41514587 | PubTator, text mining | PubMed |
| An EBNA1-YAP signaling axis drives immune escape through CD276 in EBV-associated gastric cancer. | Cell Death Dis | 2025 | 41419460 | PubTator, text mining | PubMed |
| Development and validation of a diagnostic and screening method for gastric cancer by combining new gastric cancer screening score and serum biomarkers: a prospective study. | BMC Cancer | 2025 | 41408193 | PubTator, text mining | PubMed |
| Two Cohorts, One Network: Consensus Master Regulators Orchestrating Papillary Thyroid Carcinoma. | Int J Mol Sci | 2025 | 41303715 | PubTator, text mining | PubMed |
| YAP1 Depletion Enhances TAZ and its Complexation with TEAD4 and AP-1 Heterodimer C-JUN/FOSB to Promote Gastric Cancer Progression and Metastases. | bioRxiv | 2025 | 41292957 | PubTator, text mining | PubMed |
| Arginine methyltransferase PRMT1 equipoises trophoblast development to prevent early pregnancy loss. | bioRxiv | 2025 | 41256701 | PubTator, text mining | PubMed |
| Imaging Characteristics of Pediatric Renal Cell Carcinoma and Wilms Tumor and Its Impact on Their Management and Outcomes-A Case Report and Review of Literature. | J Kidney Cancer VHL | 2025 | 41211570 | PubTator, text mining | PubMed |
| Phage Display of Graspeptides via SrtA-Mediated Peptide Ligation and Cyclization. | Org Lett | 2025 | 41186450 | PubTator, text mining | PubMed |
| The role of TEAD4 gene in the Hippo signaling pathway in triple-negative breast cancer and targeted therapy strategies. | BMC Med Genomics | 2025 | 41168787 | PubTator, text mining | PubMed |
| Targeting VGLL4 maintains extracellular matrix homeostasis and mitigates osteoarthritis in a preclinical model. | Nat Commun | 2025 | 41125571 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/7004/papers?page=4